Anti-Human CD276 Recombinant Antibody(Enoblituzumab)
-
产品编号
YR1399
-
别名
科研级 Enoblituzumab ( 依诺妥珠单抗 ), Anti-CD276 Recombinant Antibody, Research Grade Enoblituzumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1399 |
| Alias | 科研级 Enoblituzumab ( 依诺妥珠单抗 ), Anti-CD276 Recombinant Antibody, Research Grade Enoblituzumab |
| Size | 1mg, 5mg |
| Molecular Name | Enoblituzumab |
| CAS Number | 1353485-38-7 |
| Target | CD276[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators. This drug was developed by MacroGenics, Inc. |
| Application | ELISA, IHC, IF, IP, FCM, FuncS |
| Remarks | This product is for research use only. |
0